Robert Ylimaki | OMICS International
ISSN: 2155-9872

Journal of Analytical & Bioanalytical Techniques
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google scholar citation report
Citations : 3366

Journal of Analytical & Bioanalytical Techniques received 3366 citations as per google scholar report

Journal of Analytical & Bioanalytical Techniques peer review process verified at publons
Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Academic Journals Database
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • ResearchBible
  • China National Knowledge Infrastructure (CNKI)
  • Ulrich's Periodicals Directory
  • Electronic Journals Library
  • RefSeek
  • Directory of Research Journal Indexing (DRJI)
  • Hamdard University
  • OCLC- WorldCat
  • Scholarsteer
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Euro Pub
Share This Page

Robert Ylimaki

Sr. Cyclotron Engineer at IBA


 Robert Ylimaki is a doctorate from Illinois Institute of Technology in Physics. Presently the Sr. Cyclotron Engineer at IBA. He Lead operations of PET cyclotron facility, designing and building infrastructure to manufacture radiopharmaceuticals under cGMP, while fostering partnerships to launch new drug products through licensing and new drug approvals. Few of his Key Accomplishments are Prototype of cyclotron target and thermo-chromatographic recovery furnace for Iodine-124 and developed manufacturing processes and quality control for [124I]NaI documented in FDA Drug Master File number 19434 and recovered all capital investment within twelve months.

Research Interest

 HPLC, Oncology, Synchotron, Medical Imaging,Pharmaceuticals etc